Literature DB >> 22553568

Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy.

Cai-Rui Li1, Shu-Guang Sun, Wei Hong.   

Abstract

AIM: To evaluate the effect of intravitreal bevacizumab (IVB) injection 1 week before pars plana vitrectomy (PPV) in proliferative diabetic retinopathy (PDR) patients.
METHODS: A retrospective research was done on 46 PDR patients who were divided into PPV group (n=28) and IVB group (n=18, PPV with preoperative IVB). Bevacizumab was injected 1 week before PPV. Main outcome measures were visual acuity, incidence of iatrogenic retinal breaks, intraoperative and postoperative bleeding.
RESULTS: At 1 month after surgery, visual acuity in PPV (82.1%) and IVB group (88.9%) improved significantly (P<0.01) and the difference between the two groups was not significant (P>0.05). Iatrogenic retinal breaks were reported in 18 cases (64.3%) in PPV group and 4 cases (22.2%) in IVB group (P<0.05). Intraoperative bleeding was encountered in all cases in PPV group and 7 cases (39%) in IVB group (P<0.01). Postoperative bleeding was reported in 9 cases (32.1%) in PPV group and none in IVB group (P<0.01).
CONCLUSION: IVB injection before PPV is helpful in reducing iatrogenic retinal breaks, intraoperative and postoperative bleeding in PDR patients.

Entities:  

Keywords:  bevacizumab; proliferative diabetic retinopathy; vascular endothelial growth factor; vitrectomy

Year:  2010        PMID: 22553568      PMCID: PMC3340620          DOI: 10.3980/j.issn.2222-3959.2010.03.19

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  13 in total

1.  Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.

Authors:  Eric Chen; Carl H Park
Journal:  Retina       Date:  2006 Jul-Aug       Impact factor: 4.256

2.  Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy.

Authors:  K Ishikawa; S Honda; Y Tsukahara; A Negi
Journal:  Eye (Lond)       Date:  2007-09-21       Impact factor: 3.775

3.  Angiopoietin concentrations in diabetic retinopathy.

Authors:  J I Patel; P G Hykin; Z J Gregor; M Boulton; I A Cree
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

4.  Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

Authors:  Rodrigo Jorge; Rogério A Costa; Daniela Calucci; Léssia P Cintra; Ingrid U Scott
Journal:  Retina       Date:  2006 Nov-Dec       Impact factor: 4.256

5.  Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.

Authors:  Raffaello di Lauro; Pio De Ruggiero; Raffaella di Lauro; Maria Teresa di Lauro; Mario Rosario Romano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-05       Impact factor: 3.117

6.  Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab.

Authors:  Hamid Ahmadieh; Siamak Moradian; Mohsen Malihi
Journal:  Int Ophthalmol       Date:  2007-02-08       Impact factor: 2.031

7.  Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy.

Authors:  Siamak Moradian; Hamid Ahmadieh; Mohsen Malihi; Masoud Soheilian; Mohammad Hossein Dehghan; Mohsen Azarmina
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-12       Impact factor: 3.117

8.  [Subretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective study].

Authors:  C Baeteman; L Hoffart; F Galland; B Ridings; J Conrath
Journal:  J Fr Ophtalmol       Date:  2009-05-17       Impact factor: 0.818

9.  Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.

Authors:  Yusuke Oshima; Chiharu Shima; Taku Wakabayashi; Shunji Kusaka; Fumio Shiraga; Masahito Ohji; Yasuo Tano
Journal:  Ophthalmology       Date:  2009-03-09       Impact factor: 12.079

10.  Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study).

Authors:  D da R Lucena; J A S Ribeiro; R A Costa; J C Barbosa; I U Scott; L L de Figueiredo-Pontes; R Jorge
Journal:  Br J Ophthalmol       Date:  2009-02-10       Impact factor: 4.638

View more
  2 in total

1.  Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review.

Authors:  Panagiotis Dervenis; Nikolaos Dervenis; David Steel; Teresa Sandinha; Paris Tranos; Panagiotis Vasilakis; Ioannis Liampas; Chrysoula Doxani; Elias Zintzaras
Journal:  Ther Adv Ophthalmol       Date:  2021-12-06

Review 2.  Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Authors:  Jonathan M Smith; David H W Steel
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.